Jeffrey Jerome Ludwig

Insider Reports History

Location
Los Angeles, CA
Signature
/s/ Gordon Esplin as attorney-in-fact for Jeffrey Jerome Ludwig
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Jeffrey Jerome Ludwig:

Company Role Class Num Shares Value Price $ Report Date Ownership
PUMA BIOTECHNOLOGY, INC. Chief Commercial Officer Common Stock 156,792 $494,161 $3.15 07 Feb 2025 Direct
PUMA BIOTECHNOLOGY, INC. Chief Commercial Officer Stock Option (Right to Buy) 66,221 07 Feb 2025 Direct

Insider Reports Filed by Jeffrey Jerome Ludwig

Symbol Company Period Transactions Value $ Form Type Role Filing Time
PBYI PUMA BIOTECHNOLOGY, INC. 07 Feb 2025 2 $0 4 Chief Commercial Officer 11 Feb 2025, 18:55
PBYI PUMA BIOTECHNOLOGY, INC. 02 Jan 2025 1 -$29,743 4 Chief Commercial Officer 03 Jan 2025, 19:31
PBYI PUMA BIOTECHNOLOGY, INC. 17 Jul 2024 1 -$9,615 4 Chief Commercial Officer 18 Jul 2024, 19:06
PBYI PUMA BIOTECHNOLOGY, INC. 02 Jul 2024 1 -$19,778 4 Chief Commercial Officer 02 Jul 2024, 21:19
PBYI PUMA BIOTECHNOLOGY, INC. 12 Feb 2024 2 $0 4 Chief Commercial Officer 14 Feb 2024, 18:00
PBYI PUMA BIOTECHNOLOGY, INC. 03 Jan 2024 1 -$58,119 4 Chief Commercial Officer 05 Jan 2024, 19:00
PBYI PUMA BIOTECHNOLOGY, INC. 03 Jul 2023 1 -$40,075 4 Chief Commercial Officer 06 Jul 2023, 19:08
PBYI PUMA BIOTECHNOLOGY, INC. 10 Feb 2023 2 $0 4 Chief Commercial Officer 14 Feb 2023, 15:50
PBYI PUMA BIOTECHNOLOGY, INC. 03 Jan 2023 1 -$27,440 4 Chief Commercial Officer 05 Jan 2023, 16:36
PBYI PUMA BIOTECHNOLOGY, INC. 05 Jul 2022 1 -$15,355 4 Chief Commercial Officer 07 Jul 2022, 20:17
PBYI PUMA BIOTECHNOLOGY, INC. 03 Mar 2022 2 $0 4 Chief Commercial Officer 15 Mar 2022, 13:37
PBYI PUMA BIOTECHNOLOGY, INC. 03 Jan 2022 1 -$15,121 4 Chief Commercial Officer 05 Jan 2022, 19:32